Yonhap Infomax NewsApr 29, 2025
Hanmi Pharm forecasts 25% drop in Q1 operating profit due to continued underperformance of subsidiaries, despite growth in main products driving standalone results
#YonhapInfomax #HanmiPharm #Q1Earnings #OperatingProfit #BeijingHanmi #SubsidiaryPerformance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60807
Hanmi Pharm Q1 Operating Profit Expected to Decrease 25% - 'Subsidiaries' Underperformance Continues'

Hanmi Pharm forecasts 25% drop in Q1 operating profit due to continued underperformance of subsidiaries, despite growth in main products driving standalone results

Yonhap Infomax